New MRI contrast for brain tumors
Part of Brain & nervous system, Cancer, Ear, nose & throat clinical trials.
This trial uses a new type of MRI contrast dye (USPIO) to get clearer images of certain slow-growing brain tumors (vestibular schwannomas and low-grade gliomas). The goal is to see if this dye helps doctors better understand and treat these tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 16 years old or older
- Have a vestibular schwannoma or low-grade glioma brain tumor
- Be able to lie still comfortably for up to 1 hour
- No previous radiation therapy to the brain or spine
- No allergy to iron or dextran (the contrast agent used in this MRI)
- Not be pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether two special MRI contrast medicines—gadolinium and ferumoxytol—can better diagnose problems in the brain or central nervous system. It may help doctors identify what’s causing symptoms or abnormal brain findings.
This trial tests a new portable MRI machine that uses a standard contrast dye (gadolinium) to better see brain lesions like tumors or infections. It may help people who need an MRI but cannot easily get to a traditional scanner.
This trial uses special MRI scans and a contrast agent to look at the immune environment of glioblastoma tumors. It may help doctors learn more about how the tumor responds to treatment.
This study uses special scans (PET and MRI) to look at brain tumors in more detail. It aims to understand tumor metabolism and oxygen levels, which may help guide treatment.
This study tests a new contrast dye used during MRI scans of the brain or spine. It may help doctors see lesions more clearly.
This trial tests a new type of MRI scan that may help see meningioma brain tumors more clearly. It is a short imaging study for people who plan to have surgery or monitoring.
Hear when a new Vestibular Schwannoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.